Key Insights

Highlights

Success Rate

87% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

7.4%

2 terminated out of 27 trials

Success Rate

86.7%

+0.2% vs benchmark

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

38%

5 of 13 completed with results

Key Signals

5 with results87% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (13)
P 2 (3)
P 3 (1)

Trial Status

Completed13
Unknown7
Recruiting3
Terminated2
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

86.7%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT07394127Not ApplicableCompleted

Effects of Inspiratory Muscle Training Added to a Swimming Program in Children With Asthma

NCT07508267Not ApplicableCompletedPrimary

Thoracic Spine Rotation Stretching and Scapular Retraction in Asthma Patients

NCT06364527Not ApplicableCompletedPrimary

Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma

NCT07477080Not ApplicableCompletedPrimary

Breathing Exercises Effect on Lung Functions and Chest Expansion in Asthmatics

NCT06596512Not ApplicableNot Yet Recruiting

Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

NCT04613245CompletedPrimary

Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19

NCT06273072Phase 2Recruiting

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

NCT04593394CompletedPrimary

Inducible Laryngeal Obstruction in Severe Asthma in Severe Asthma

NCT06377345Not ApplicableRecruiting

Remote Patient Monitoring Solution for Chronic Respiratory Disease Management

NCT05609760Not ApplicableTerminatedPrimary

Pictograms to Facilitate Comprehension of Medical Indications

NCT05572177Not ApplicableRecruitingPrimary

Feasibility of a Smartphone Application for Asthma Self-management

NCT03788057Not ApplicableCompletedPrimary

Inflammatory Indices in Predicting the Failure of Inhaled Corticosteroids Reduction in Young Participants With Asthma

NCT04456270Completed

Asthma Control in a Dutch Primary Care Population

NCT05270278Completed

Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy

NCT03736629Phase 2TerminatedPrimary

Azithromycin Treatment for the Airway Microbiome in Asthma

NCT05841901Not ApplicableUnknownPrimary

Huang-long Zhi-xiao Granule Improves the Control Rate of Chronic Persistent of Asthma

NCT05432440Not ApplicableUnknown

Evaluation of Pharmacist-guided Digital-based Asthma Education for Indonesian Children With Asthma

NCT05304494Withdrawn

Sentinel - Triaging Acute Breathlessness Using Multi-Modal Biomarkers

NCT02227394Phase 2Completed

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

NCT03036267Not ApplicableCompletedPrimary

Feasibility of the BREATHE Asthma Intervention Trial

Scroll to load more

Research Network

Activity Timeline